Application
Western blot analysis of NRBF2 Antibody (Center) (Cat.# AP1828e) in CEM, MCF-7 cell line lysates (35ug/lane). NRBF2 (arrow) was detected using the purified Pab.Application
NRBF2 Antibody (Center-2) flow cytometry analysis of HepG2 cells (bottom histogram) compared to a negative control cell (top histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | NRBF2 Antibody (Center-2) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | NRBF2; COPR; Nuclear receptor-binding factor 2; Comodulator of PPAR and RXR |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:50~100 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | COPR |
|---|---|
| Alternative Names | NRBF2 COPR Nuclear receptor-binding factor 2 Comodulator of PPAR and RXR |
| Molecular Weight(MW) | 32378 Da |
| Function | May modulate transcriptional activation by target nuclear receptors. Can act as transcriptional activator (in vitro) |
| Tissue Specificity | Detected in keratinocytes, liver and placenta. |
| Cellular Localization | Nucleus (By similarity). Cytoplasm (By similarity) |
| Entrez Gene | 29982 |
|---|
Application
Western blot analysis of NRBF2 Antibody (Center) (Cat.# AP1828e) in CEM, MCF-7 cell line lysates (35ug/lane). NRBF2 (arrow) was detected using the purified Pab.
Application
NRBF2 Antibody (Center-2) flow cytometry analysis of HepG2 cells (bottom histogram) compared to a negative control cell (top histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:50~100 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
